Signalling possible drug-drug interactions in a spontaneous reporting system: Delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole

British Journal of Clinical Pharmacology

Volumn 47, Issue 6, 1999, Pages 689-693

  Van Puijenbroek, Eugène P ^a   Egberts, Antoine C G ^b,c   Meyboom, Ronald H B ^a   Leufkens, Hubert G M ^b  

^a NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c GGZ Midden Brabant   (Netherlands)

Author keywords

Drug interactions; Itraconazole; Oral contraceptives; Pharmacovigilance; Signal detection; Withdrawal bleeding

Indexed keywords

ITRACONAZOLE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; RISK;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CONTRACEPTIVES, ORAL; DRUG INTERACTIONS; FEMALE; HUMANS; ITRACONAZOLE; MENSTRUATION DISTURBANCES; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0033061701     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00957.x     Document Type: Article

References (16)

1. 1 De Koning GHP. A regionalized spontaneous surveillance program for adverse drug reactions as a tool to improve pharmacotherapy |thesis|. Utrecht University; 1993.
2. 2 Finney DJ. Systematic signalling of adverse reactions to drugs. Meth Inform Med 1974; 13: 1-10.
3. 3 Stricker BHCh, Tijssen JG. Serum sickness-like reactions to cefaclor. J Clin Epidemiol 1992; 45: 1177-1184.
4. 4 Egberts ACG, Meyboom RHB, de Koning GHP, Bakker A, Leufkens HGM. Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol 1997; 44: 277-281.
5. 5 Van Puijenbroek EP, Feenstra J, Meyboom RHB. Verstoring van de pilcyclus tijdens het gelijktijdig gebruik van itaconazol en orale anticonceptiva. Ned Tijdschr Geneeskd 1998; 142(3): 146-149.
6. 6 Meyboom RHB, Van Puijenbroek EP, Vinks MHAM, Lastdrager CJ. Disturbance of withdrawal bleeding during concomitant use of itraconazole and oral contraceptives. N Z Med J 1997; 110: 300.
7. 7 Carson JL, Strom BL, Maislin G. Screening for unknown effects of newly marketed drugs. In: Pharmacoepidemiology. Second Edition, New York: John Wiley & Sons, 1994: 431-447.
8. 8 Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? Br Med J 1998; 316: 989-991.
9. 9 Amery W. Analysis of the information in a central ADE database. Intern J Risk Safety in Med 1993; 5: 123.
10. 10 Meyboom RHB, Heymeijer GWJ, Van den Bemt PMLA, de Koning GHP. Disturbance of menstruation as a side effect of nonsteroidal antiinflammatory drugs (NSAIDs). Pharmacoepidemiology and Drug Safety 1995; 4: 161-163.
11. 11 Milstien JB, Faich GA, Hsu JP. Factors affecting physician reporting of adverse drug reactions. Drug Inf J 1986; 20: 157-164.
12. 12 Tubert-Bitter P, Bégaud B. Comparing safety of drugs. Post Marketing Surveillance 1993; 7: 119-137.
13. 13 Tubert Bitter P, Begaud B, Moride Y, Chasleric A, Haramburu F. Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approach. J Clin Epidemiol 1996; 49: 121-123.
14. 14 Stockley IH. Drug interactions. Fourth Edition. Oxford: Blackwell Science, 1996.
15. 15 Back DJ, Tjia JF. Azoles and allylamines: the clinical implications of interaction with cytochrome P450 enzymes. J Dermatol Treatment 1990; 1 (suppl 2); 11-13.
16. 16 Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ. Ketoconazole and sulfaphenazole as the respective selective inhibitors of P450 3A and 2C9. Xenobiotica 1995; 25: 261-270.